Recently, anti-CAF therapy approaches have been developed for cancer immunotherapy; these included FAP depletion, blocking CAF function using inhibitors such as CXCR4 inhibitor and JAK inhibitor, altered CAF activation by vitamin A and D, and ECM-targeted therapy by associated signaling pathways and proteins [15]. Here, FAP is linked to cancer.